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Natural killer (NK) lymphocyte-mediated cytotoxicity and cytokine secretion control 
infections and cancers, but these crucial activities decline with age. NK cell develop-
ment, homeostasis, and function require IL-15 and its chaperone, IL-15 receptor alpha 
(IL-15Rα). Macrophages and dendritic cells (DC) are major sources of these proteins. We 
had previously postulated that additional IL-15 and IL-15Rα is made by skeletal muscle 
and adipose tissue. These sources may be important in aging, when IL-15-producing 
immune cells decline. NK  cells circulate through adipose tissue, where they may be 
exposed to local IL-15. The objectives of this work were to determine (1) if human mus-
cle, subcutaneous adipose tissue (SAT), and visceral adipose tissue (VAT) are sources of 
IL-15 and IL-15 Rα, and (2) whether any of these tissues correlate with NK cell activity 
in elderly humans. We first investigated IL-15 and IL-15Rα RNA expression in paired 
muscle and SAT biopsies from healthy human subjects. Both tissues expressed these 
transcripts, but IL-15Rα RNA levels were higher in SAT than in skeletal muscle. We 
also investigated tissue obtained from surgeries and found that SAT and VAT expressed 
equivalent amounts of IL-15 and IL-15Rα RNA, respectively. Furthermore, stromal 
vascular fraction cells expressed more IL-15 RNA than did adipocytes. To test if these 
findings related to circulating IL-15 protein and NK cell function, we tested 50 healthy 
adults aged > 70 years old. Plasma IL-15 levels significantly correlated with abdominal 
VAT mass in the entire cohort and in non-obese subjects. However, plasma IL-15 levels 
did not correlate with skeletal muscle cross-sectional area and correlated inversely with 
muscle strength. Plasma IL-15 did correlate with NK cell cytotoxic granule exocytosis 
and with CCL4 (MIP-1β) production in response to NKp46-crosslinking. Additionally, 
NK  cell responses to K562 leukemia cells correlated inversely with muscle strength. 
With aging, immune function declines while infections, cancers, and deaths increase. 
We propose that VAT-derived IL-15 and IL-15Rα is a compensatory NK cell support 
mechanism in elderly humans.
Keywords: natural killer cell, adipose tissue, il-15, skeletal muscle strength, aging
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inTrODUcTiOn
Natural killer (NK) cells are classified as members of the type 
1 innate lymphoid cells (1). NK  cells defend against infection, 
both directly and by orchestrating T  cell, DC, monocyte, and 
macrophages (Mφ) responses (2). NK  cells also may eliminate 
cancer cells and senescent cells (3, 4). Peripheral NK cells develop 
in the bone marrow and secondary lymphoid organs, where they 
are nurtured by multiple cell types and cytokines. IL-15, which is 
critical for mature NK cell development, homeostasis and func-
tion (5), signals via a trimeric receptor comprised of IL-15Rα, 
CD122, and CD132. IL-15 RNA is made in the bone marrow, 
secondary lymphoid tissues, and many nonlymphoid tissues, 
including skeletal muscle and adipose tissue. Although IL-15Rα 
is part of the IL-15 receptor, it also is required for IL-15 secretion 
and appearance on cell surfaces. In Mφ, DC, and other producing 
cells, IL-15 and IL-15Rα bind together with very high affinity. 
The complex is transported to the cell surface, where it stimulates 
neighboring NK cells in a paracrine fashion (5, 6). IL-15/IL-15Rα 
complexes also circulate to act on NK cells in an endocrine fashion 
(7). Two observations indicate that physiological IL-15 levels are 
dose-limiting for NK cells homeostasis: hemizygous IL-15 mice 
have low NK cell number and exogenous IL-15 boosts NK cell 
number in both normal mice and primates (8–10).
Human NK cells are classified into two major subsets based on 
their CD56 surface expression. Most circulating blood NK cells 
are CD56dim, while 5–15% are CD56bright. CD56bright NK  cells 
are poorly cytotoxic but secrete high levels of cytokines and 
chemokines in response to inflammatory cytokines. Although 
CD56dim NK  cells respond weakly to inflammatory cytokines, 
they kill target cells (such as the erythroleukemia cell line K562) 
and secrete chemokines and cytokines in response to antibody-
coated cells and tumor cells.
Natural killer cell numbers are maintained in healthy elderly 
people, but NK-mediated cytotoxicity and secretion of immu-
noregulatory cytokines and chemokines decline with age (11, 12). 
Aging-related NK defects in mice are due, at least in part, to inef-
fective support from stromal cells (13–15). These defects could 
be due to decreased Mφ and dendritic cell IL-15 production 
and presentation (13, 15). Decreased NK cell activity in elderly 
people correlates with an increased incidence and severity of viral 
and bacterial infections and deaths (11, 16). Moreover, low NK 
function was found to be associated with increased cancer rates 
in subsequent years (17).
The objectives of this work were to determine (1) if human 
muscle, subcutaneous adipose tissue (SAT), and visceral adipose 
tissue (VAT) are sources of IL-15 and IL-15 Rα, and (2) whether 
any of these tissues correlate with NK  cell activity in elderly 
humans. We found that IL-15 and IL-15Rα RNA are expressed 
in muscle, SAT, and VAT, but with relatively lower IL-15Rα RNA 
levels in skeletal muscle. Because skeletal muscle produces high 
levels of IL-15 RNA, we initially hypothesized that relatively 
strong elderly individuals would have higher IL-15 levels and 
more robust NK cell response (18). Contrary to our prediction, 
we found that plasma IL-15 level did not associate with lean tis-
sue mass, but rather with VAT. Additionally, NK  cell response 
inversely correlated with muscle strength.
MaTerials anD MeThODs
subjects
In accordance with the Declaration of Helsinki (modified in 
2008), all protocols were approved by the Institutional Review 
Board of the University of Kentucky, Lexington, KY, USA. All 
subjects were made aware of the design and purpose of the stud-
ies, and all subjects signed consent forms. The cohorts are sum-
marized in Table S1 in Supplementary Material, with additional 
information provided in some of the figure legends. Cohort A 
vastus lateralis muscle and SAT biopsies from healthy research 
subjects were frozen in liquid nitrogen and stored at −80°C. 
Cohort B SAT and VAT were obtained from discarded surgery 
specimens, immediately put on ice for no more than 3  h, and 
immediately processed into stromal vascular fraction (SVF) and 
adipocyte fractions or stored at −80°C. Cohort C VAT, including 
mesenteric fat, epiploic appendages, and omentum were obtained 
from discarded surgery specimens, immediately snap frozen in 
liquid nitrogen, and stored at −80°C. Cohort D blood samples 
were obtained between 9:30 a.m. and 12:45 p.m. and kept at room 
temperature until processing within 2 h of collection.
Flow cytometry and nK cell stimulation
As described in Ref. (19), whole blood was diluted with PBS 
and the mononuclear cells were recovered using Lymphoprep® 
lymphocyte separation medium (Axis-Shield, Oslo, Norway). For 
antibody staining, ~0.5 × 106 fresh mononuclear cells were washed 
and incubated with human IgG for 15 min at room temperature 
to block Fc-receptor binding and then stained on ice for 30 min 
with combinations of fluorescently labeled mAb, including those 
specific for CD3, CD16, and CD56 to allow for identification of 
CD56bright and CD56dim subsets (19). After washing, the cells were 
analyzed on a LSR-II flow cytometer (BD, San Jose, CA, USA), and 
data were processed using FlowJo software. Fresh mononuclear 
cells (0.5 × 106) were rested overnight and then stimulated with 
1 × 106 K562 cells for 3 h at 37°C. Alternatively, mononuclear cells 
were cultured overnight with 0.5 µg/L IL-12 and then transferred 
to polystyrene plates coated with anti-NKp46 mAb for 3 h. Cells 
were stained with mAb to CD3, CD16, CD56, and CD107a. Cells 
also were fixed in 2% paraformaldehyde solution, then permeabi-
lized (1× Permeabilization buffer, eBioscience) and stained with 
anti-IFN-γ and anti-MIP-1β mAb.
Body composition and strength 
Measurements
In cohort D, body composition was measured by dual X-ray 
absorptiometry (DXA) using a GE Lunar iDXA. Standardized 
methods for regional partitioning and phantom calibrations 
were employed to ensure data quality. Scans were analyzed using 
the GE Lunar software v10.0 in order to calculate fat-free mass 
Abbreviations: aLM/BMI, appendicular lean mass divided by BMI; BMI, body 
mass index; CT, computed tomography; DC, dendritic cell; DXA, dual X-ray 
absorptiometry; MIP-1β, chemokine CCL4; Mφ, macrophage; SAT, subcutaneous 
adipose tissue; SVF, stromal vascular fraction; VAT, visceral adipose tissue.
3
Al-Attar et al. Adipose IL-15, Strength, NK Cells
Frontiers in Immunology | www.frontiersin.org March 2018 | Volume 9 | Article 440
(kg), mineral-free lean mass (kg), fat mass (kg), and percent fat. 
Leanness is a significant risk factor for health outcomes in the 
elderly (20, 21) and was calculated as appendicular lean mass 
divided by body mass index (BMI). aLM was calculated as the sum 
of lean soft tissue in both the right and left arms and legs where 
limbs were isolated from the trunk by using DXA pre-defined 
regional lines with manual adjustment. Computed tomography 
(CT) is described in Supplementary Material.
Measures of strength included isometric and isokinetic knee 
extension testing on a Biodex System 4 dynamometer. Subjects 
were given a familiarization training session to acclimate to the 
testing protocol. During testing sessions, isometric measurements 
of peak torque and time to peak torque were completed with the 
subject seated with hip and knee angles at 85° and 90°, respec-
tively. Peak torque was recorded as the highest torque achieved 
over three trials, whereas time to peak was recorded as the time in 
seconds to reach peak torque. Knee extensor isokinetic strength 
testing was completed at 90 degrees per second. We assessed peak 
torque, time to peak torque, total work, and average power over 
three trials.
il-15 assay
Plasma IL-15 was measured with the QuantiGlo Chemiluminescent 
Immunoassay kit (R&D Systems) in two independent experi-
ments, as described in Ref. (19).
adipose Tissue Fractionation and Muscle 
and adipose Tissue rna
Subcutaneous adipose tissue and VAT samples were either frozen 
at −80°C if unfractionated, or immediately processed if they 
were to be separated into adipocyte and SVF. Unfractionated 
fat (~200 mg) or muscle (100 mg) were mixed with zirconium 
oxide beads and 1.0 mL of TRIzol (Thermo-Fisher) in a 1.6 ml 
microcentrifuge tube (Thermo-Fisher) and treated with a tissue 
disruptor (Bullet Blender Storm 5, Next Advance) at full speed for 
2 min. RNA was purified from the homogenized samples using the 
RNAeasy Lipid Tissue Mini kit (Qiagen). Nucleic acid (~1.0 μg) 
was next treated with DNase 1 (Promega). After DNase inactiva-
tion, RNA was reverse transcribed using the RNA to cDNA high 
capacity kit (Thermo-Fisher), following manufacturer protocol.
To prepare adipocyte and SVF fractions, 10–15 g of fresh SAT 
or VAT was washed thoroughly with Hanks balanced salt solu-
tion (HBSS, Sigma), minced, and after clots and connective tissue 
was removed, subdivided into two 50 mL polypropylene conical 
tubes. Each tube contained 25 mL of HBSS supplemented with 
40 mM HEPES (pH 7.2), 1.0% BSA (Fraction V, Bioworld), 2 mM 
CaCl2 and 0.1% collagenase (Type 1, Worthington, OH, USA). 
Tubes were gently agitated on an orbital shaker for 3 h at room 
temperature, centrifuged at 12  ×  g for 5  min, and the floating 
adipocyte layer and undigested fat was removed. This fraction 
was sent through a 500 µm steel mesh filter to remove undigested 
fat and washed once with HBSS. Approximately 0.1–0.2 mL of 
this fraction was treated with 0.9  mL of TRIzol. The SVF was 
centrifuged at 300 × g and then treated with 1.0 mM EDTA-HBSS 
in at 37 C for 15 min and centrifuged at 300 × g. Pelleted cells were 
resuspended in HBSS in 1.0 mM EDTA, sent through a 70 µm 
filter to remove large adipocytes, centrifuged, and solubilized 
with 1.0 mL of TRIzol. For both adipocytes and SVF, RNA was 
purified and cDNA prepared as described above.
qPCR
Primers and primer design are described in Supplementary 
Material. We wished to estimate the IL-15 and IL-15Rα RNA 
that was made by adipocytes and SVF cells. Here, we distinguish 
contaminating adipocytes from all other SVF cells, which likely 
includes pre-adipocytes. We first used differentiated adult- 
de rived human adipose stem cells (22) to confirm that adipocytes 
do not contain CD45 RNA. The SVF CD45 level was only 5% of 
that of blood mononuclear cells. Using this very conservative 5% 
level, we estimated the SVF RNA contamination of the adipocyte 
fraction, which had a median of 2.27%. Based on this measure-
ment, we reasoned that the adiponectin level in the adipocyte 
fraction would closely estimate the percentage adipocyte RNA. 
We then used the adiponectin RNA level in the SVF to calculate 
the percentage of adipocyte RNA, which was a median of 0.5% 
compared to adipocytes. Using the amount of adiponectin signal 
in each SFV, we calculated the amount of IL-15 and IL-15Rα RNA 
that came from SVF cells.
statistical analysis
All statistical tests were run using IBM SPSS Software (version 24, 
Armonk, NY, USA). The strength and direction of associations 
were evaluated using the nonparametric Spearman rank-order 
correlation coefficient (Spearman’s correlation, for short) or 
the Pearson product-moment correlation coefficient (Pearson’s 
correlation, for short). Linear regression analysis was used to 
quantify how well two variables relate to each other. When two 
or more independent variables were hypothesized to affect the 
outcome, multiple regression analysis was used. When sample 
groups were not normally distributed, differences between 
groups were compared by related samples Wilcoxon Singed Rank 
Testing. All histogram charts represent single values. Significance 
was set at <0.05. For box-and-whisker plots, the center lines show 
the medians; box limits indicate the 25th and 75th percentiles, 
whiskers extend 1.5 times the interquartile range from the 25th 
and 75th percentiles. Box and whisker graphs were plotted using 
BoxPlotR (http://shiny.chemgrid.org/boxplotr/).
resUlTs
il-15 and il-15rα rnas are Produced in 
Paired human saT and Muscle samples
Natural killer cell and other innate immune functions decline 
with age. We hypothesized that IL-15 and its chaperone, IL-15Rα, 
are secreted from skeletal muscle, SAT, and VAT and influence 
NK number and function. Therefore, we measured IL-15 and 
IL-15Rα RNA levels in paired samples of vastus lateralis muscle 
and abdominal SAT from eight healthy cohort A adult subjects 
(cohorts are described in Table S1 in Supplementary Material). 
IL-15 RNA levels in muscle and SAT were not significantly dif-
ferent, but SAT expressed more of the IL-15 chaperone, IL-15Rα. 
These data are presented as a ratio of SAT RNA level to muscle 
FigUre 1 | IL-15 and IL-15Rα RNA levels in abdominal subcutaneous 
adipose tissue (SAT) normalized to values in paired vastus lateralis muscle 
samples in measured by RT-qPCR and normalized to four housekeeping 
genes in cohort A. Shown are means plus SEM. Each symbol for IL-15 and 
IL-15Rα represents an individual donor. IL-15 level did not significantly differ 
between tissues, but SAT expressed significantly more IL-15Rα RNA than  
did skeletal muscle (p = 0.012). Cohort A is described in Table S1 in 
Supplementary Material.
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RNA level in the same individual (Figure 1). This result indicates 
that fat is a significant source of IL-15 and IL-15Rα RNA and 
that IL-15Rα RNA level is higher in SAT, compared with skeletal 
muscle from the same individual.
il-15 and il-15rα rnas are Produced by 
both VaT and saT
We extended these findings by measuring the IL-15 and IL-15Rα 
transcript levels in SAT and VAT. Non-paired samples of SAT and 
VAT from surgeries were processed in cohorts B and C. The levels 
of IL-15 and IL-15Rα transcripts are shown in Figures 2 and 3. 
As indicated in the figure legend, some VAT samples were from 
donors with inflammatory conditions (e.g., cancer), but transcript 
levels from these samples did not differ from donors without 
inflammatory conditions, such as hernia repair (Figures 2 and 3). 
Both SAT and VAT produced considerable IL-15 and IL-15Rα 
RNA (Figure 2). VAT from the mesentery, epiploic appendages, 
and omentum all produced IL-15 and IL-15Rα RNAs (Figure 3). 
IL-15 and IL-15Rα RNA levels occasionally differed between 
VAT depots, but the differences were not found in all subjects. 
For example, IL-15Rα RNA was higher in epiploic fat than in 
mesenteric fat in subject 21, but the opposite was true in subject 
26 (Figure 3).
sVF cells Produced More il-15 rna than 
Did adipocytes
Adipose tissue is comprised of adipocytes, pre-adipocytes, 
stromal cells, and a variety of leukocytes (23), any one of which 
could be a source of IL-15 and IL-15Rα. To understand which 
cells produce IL-15 and IL-15Rα transcripts, fresh SAT and VAT 
received from surgery were fractionated into adipocyte fraction 
and SVF. Figure  4 shows that SVF cells expressed more IL-15 
RNA than did adipocytes from the same tissue sample. IL-15Rα 
RNA levels did not differ significantly between the paired sam-
ples. From these results, we propose that VAT IL-15 largely comes 
from SVF cells, which likely include Mφ.
Plasma il-15 level Directly correlated 
with VaT
We hypothesized that non-lymphoid sources of IL-15 and IL-15Rα 
may influence plasma IL-15 levels and NK  cell activity in the 
elderly. To test our hypothesis, we recruited 50 healthy adults aged 
>70 years old and correlated their body composition to plasma 
IL-15 levels and to NK  cell number and function (cohort D). 
In these elderly subjects, IL-15 plasma levels did not differ by 
gender (19). IL-15 correlated strongly with CT measures of total 
abdominal fat and VAT (Figure  5A), but not with abdominal 
SAT (Table  1). The correlation between IL-15 and VAT was 
even stronger when analysis was limited to non-obese subjects 
(BMI < 30; data not shown). Because cytomegalovirus (CMV) 
infection is life-long and profoundly affects the human immune 
system (12), we tested whether the correlation between IL-15 and 
VAT could be explained by CMV infection status. CMV did not 
correlate with NK cell response to multiple different stimuli (24). 
Importantly, the correlation between VAT and IL-15 remained 
strong when CMV status was included as a factor in multifacto-
rial analysis (Table 1). In multifactorial testing, the associations 
of IL-15 with other adipose depots were not significant when VAT 
was included as a factor (Table 1). Together, these data indicate 
that amount of VAT, but not other adipose depots, predicts circu-
lating IL-15 concentration in elderly subjects.
The elderly subject cohort D showed 
expected sex Differences and had low 
c-reactive Protein level
As expected, men had significantly greater muscle mass, bone min-
eral content, fat-free mass, and android fat, whereas women had 
more gynoid and leg fat by DXA and more SAT by CT (data not 
shown). Men had more VAT than women by CT, but this difference 
was not significant. For all subjects, C-reactive protein levels were 
<10 mg/L, indicating a lack of marked inflammatory disease (data 
not shown). As expected, C-reactive protein level correlated with 
measures of adipose tissue and inversely with leanness. C-reactive 
protein correlated directly with IL-15 (data not shown), suggesting 
a link between systemic inflammation and circulating IL-15 level.
nK cell activity Directly correlated with 
il-15 level
To investigate whether or not plasma IL-15 correlated with 
NK cell activity, we stimulated elderly cohort D peripheral blood 
FigUre 3 | IL-15 and IL-15Rα RNA are expressed in epiploic appendage (E), mesenteric (M), and omental (O) VAT. Cohort C subjects had surgeries for hernia 
repair (male #22, female #23, male #25), ostomy reversal (male #24), rectal intussusception (female #18), malfunctioning ileal conduit (male #19), large bowel 
obstruction (female #20), cancer (male #21, male #26, female #27, female #28), and acute appendicitis (male #29). Cohort C is described in Table S1 in 
Supplementary Material.
FigUre 2 | IL-15 and IL-15Rα RNA are produced in both subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT). Except for one sample, all cohort B 
SAT samples were from females, from surgeries for panniculectomy (7), ventral hernia (1), breast reduction (4), and mastectomy (1). VAT subjects had surgeries for 
hernia repair (1), nephrectomy (3), colectomy (12), and gastrectomy (1). Cohort B is described in Table S1 in Supplementary Material.
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mononuclear cells in  vitro with K562 leukemia cells or with 
low-level IL-12 and immobilized anti-NKp46 antibody, which 
are well-known NK cell stimuli. Using flow cytometry, we meas-
ured the ability of CD56bright and CD56dim NK  cells to produce 
IFN-γ and MIP-1β. We also measured their cytotoxic response, 
as assayed by the appearance of the CD107a cytotoxic granule 
marker on the cell surface. Plasma IL-15 level correlated with the 
CD56dim NK cell MIP-1β and CD107a, but not IFN-γ, responses 
to NKp46 crosslinking (Table S2 in Supplementary Material). The 
correlations between NKp46-stimulated responses and plasma 
IL-15 level remained significant when correcting for age and 
gender. The responses to NKp46 did not significantly correlate 
with the responses to K562 leukemia cells, indicating that these 
two assays measure distinct aspects of NK cell signaling (data not 
shown). This is not surprising because NK cell responses to K562 
largely depend upon NKp30 and NKG2D (25).
nK cell activity inversely correlated with 
Muscle strength
We compared NK  cell responses and muscle strength. Mature 
CD56dim NK cell responses to K562 leukemia cells showed inverse 
correlations with muscle strength, as measured by knee extensor 
FigUre 4 | Subcutaneous adipose tissue (SAT) (a) and visceral adipose tissue (VAT) (B) stromal vascular fraction (SVF) cells produced more IL-15 RNA than did 
adipocytes (p = 0.012 and p = 0.043, respectively, by Wilcoxon Signed Rank Test) in cohort B. IL-15Rα RNA levels did not significantly differ between SVF and 
adipocytes. Adipocyte (A Adipo) and non-adipocyte (SVF Non-adipo) were calculated to exclude contaminating cells as described in Section “Materials and 
Methods.” All but one SAT samples were from female patients. SAT samples were from breast reductions (5), panniculectomy (4), and ventral hernia repair (1). None 
of the SAT cases involved cancer or other inflammatory diseases. VAT samples were from colectomies (5), exploratory laparotomy (1), and gastrectomy (1). Two VAT 
cases did not involve cancer. Cohort B is described in Table S1 in Supplementary Material.
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peak torque (Figure  6; Table S2 in Supplementary Material), 
isometric peak torque, and average power (data not shown). Both 
CD56dim NK cell responses to K562 target cells were significant or 
trended against strength after factoring in age and sex (Table S2 
in Supplementary Material). As expected, skeletal muscle mass 
correlated with strength in this elderly cohort D (data not shown). 
Notably, both CD56dim NK  cell degranulation (as measured by 
CD107a) and MIP-1β responses to K562 cells robustly inversely 
associated with strength after factoring in either thigh muscle 
mass or leanness (Table S2 in Supplementary Material and data 
not shown). This indicates that muscle quality substantially and 
inversely associated with NK  cell response to leukemia cells. 
As with other associations, CMV status did not weaken this 
inverse correlation (Table S2 in Supplementary Material).
Interestingly, SAT, but not VAT, correlated with the density of 
CD38 expression on both CD56bright and CD56dim NK cells (Table 
S3 and Figure S1 in Supplementary Material), which is described 
and discussed in Supplementary Material.
strength inversely correlated with Plasma 
il-15 in elderly humans
Because IL-15 is anabolic for skeletal muscle in some situations 
and skeletal muscle itself may be a source of IL-15, we predicted 
TaBle 1 | Correlations with plasma IL-15 level in Cohort D.a
Parameter spearman reg. (age, sex)b reg. [visceral adipose 
tissue (VaT)]c
reg. (torque)d reg. [cytomegalovirus 
(cMV)]e
Computed 
tomography (CT) fat
Abdomen 0.391, 0.005 0.325, 0.027 0.181, 0.336
Abdominal subcutaneous 
adipose tissue
0.171, 0.241 0.156, 0.355 0.135, 0.327
VAT 0.442, 0.001 0.450, 0.002 0.423, 0.001 0.372, 0.007
Dual X-ray  
absorptiometry fat
Total 0.334, 0.018 0.286, 0.053 0.160, 0.317
Legs 0.232, 0.105 0.125, 0.360 0.165, 0.232
Trunk 0.342, 0.015 0.334, 0.020 0.117, 0.507
Android 0.302, 0.033 0.327, 0.019 0.047, 0.805
Other Appendicular lean mass 
divided by BMI
−0.344, 0.014 −0.743, 0.001 −0.388, 0.003 −0.313, 0.100
Muscle areaf −0.244, 0.091 −0.155, 0.394 −0.417, 0.004 0.030, 0.860
Knee torque −0.348, 0.014 −0.598, 0.021 −0.397, 0.002 −0.352, 0.010
aThe correlation coefficient and the significance are show in each cell. Significant associations are underlined.
bLinear regression corrected for influence of age and gender.
cLinear regression corrected for influence of VAT.
dLinear regression corrected for influence of knee extensor peak torque.
eLinear regression, corrected for influence of CMV infection.
fCT-measured thigh muscle cross-sectional area.
A B
FigUre 5 | Plasma IL-15 level associates with visceral adipose tissue (VAT) (a) and inversely associates with knee extensor peak torque (B) in cohort D. 
Associations of IL-15 with VAT were significant in all subjects (ρ = 0.442, p = 0.001) and in males (ρ = 0.657, p < 0.001), but not in females tested separately. IL-15 
inversely associated with strength in all subjects (ρ = −0.348, p = 0.014) and in females (ρ = −0.581, p = 0.004), but not in males considered separately. Cohort D 
is described in Table S1 in Supplementary Material.
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that skeletal muscle and plasma IL-15 would directly correlate 
(18). However, there was no significant association between 
skeletal muscle mass and plasma IL-15 (Table 1). Because muscle 
mass declines less rapidly in elderly people than does strength, we 
searched for an association between strength and IL-15. We found 
a significant inverse correlation between IL-15 and knee extensor 
peak torque (Table 1; Figure 5B). This inverse association was 
confirmed when sex and age were included in multifactorial 
analysis; the inverse association became even more robust when 
VAT was included as a factor in multifactorial analysis (Table 1), 
indicating that this correlation is not confounded by VAT vol-
ume. Likewise, the correlation remained strongly negative when 
a role for CMV infection status was tested, suggesting that this 
correlation is not dependent on CMV status. When both knee 
extensor peak torque and thigh muscle cross-sectional area were 
compared, muscle strength, but not muscle cross-sectional area, 
was significant (Table 1).
DiscUssiOn
The objectives of this work were to determine (1) if human 
muscle, SAT, and VAT are sources of IL-15 and IL-15 Rα, and 
(2) whether any of these tissues correlate with NK cell activity in 
elderly humans. We found that skeletal muscle, SAT, and VAT all 
A
B
FigUre 7 | Observed associations (a) and proposed mechanistic 
relationships (B) between adipose tissue, IL-15, natural killer (NK) cells, and 
muscle. (a) Positive associations are represented by green arrows. Inverse 
associations are represented by red arrows. All arrows are double-headed, 
indicating that associations do not necessarily imply mechanism. Mechanistic 
model (B) is based on our findings and on published literature. Stimulatory 
mechanisms are represented by green arrows and inhibitory mechanisms are 
represented by the red arrow. Double-headed green arrows indicate mutually 
positive stimulation. We propose that adipose tissue is a significant source of 
IL-15, especially in aging humans. IL-15 stimulates NK cells. Importantly, 
IL-15 forms part of a positive feedback loop between adipose tissue 
NK cells, other type 1 innate lymphocytes, and macrophages, as represented 
by the double-headed green arrows. IL-15 and other inflammatory agents 
weaken muscle.
A B
FigUre 6 | Strength (knee extensor peak torque) correlates inversely with measures of mature CD56dim natural killer (NK) cell responses to K562 leukemia cells in 
cohort D. CD56dim NK cell CD107a (a) is a measure of cytotoxic granule release and correlated inversely with peak torque for all subjects (ρ = −0.475, p = 0.001), 
but not for each sex considered individually. CD56dim NK cell MIP-1β chemokine production (B) correlated inversely with peak torque for all subjects (ρ = −0.384, 
p = 0.006), but not for each sex considered individually.
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produced IL-15 and IL-15Rα RNA. Of these, only VAT correlated 
with IL-15 plasma levels in elderly human subjects. Our findings 
suggest that VAT may support NK homeostasis and activity in 
the elderly, when IL-15-producing immune cells have declined.
Other studies indicate that adipose tissue may be a significant 
source of IL-15. Dozio et  al. (26) found that mouse epicardial 
fat, a type of VAT, expressed IL-15 and IL-15Rα RNA. Hickner 
and co-workers found that human abdominal SAT and skeletal 
muscle produce IL-15; and that SAT interstitial IL-15 level was 
higher in obese vs. lean young adults (27). Like us, this group 
found IL-15 blood levels did not correlate with total body mass 
(27). Another group found that IL-15 level was higher in VAT 
tissue homogenates from obese vs. lean middle-aged people (28). 
Liou et al. (29) showed that mouse adipocytes make significant 
amounts of IL-15 and that optimal NK cell development required 
adipocyte IL-15. Using parabiotic mouse pairs, O’Sullivan found 
that NK cells recirculate between the blood and the VAT compart-
ments (30). This indicates that circulating NK cells are exposed 
to cytokines in the VAT (Figure 7B). Christiansen et al. found 
that young adult subjects placed on 12-week regimes of reduced 
caloric intake had significant IL-15 declines (31). This study sug-
gests that negative caloric balance lowers IL-15 level and because 
caloric restriction usually leads to loss of fat, is consistent with 
our finding that increased VAT directly correlated with plasma 
IL-15 level (Figure 7B).
We attempted to determine if human skeletal muscle and fat 
derived IL-15 and IL-15Rα may correlate with NK activity in the 
elderly. Definitive experimental manipulation of human subjects 
is not possible, but we identified strong correlations between 
body composition parameters, IL-15 plasma levels, and NK cell 
function. We restricted our main analysis to elderly people 
because a prior study had suggested a correlation between BMI 
and NK cell number in elderly women, but not in young women 
(18). Additionally, because excess VAT and SAT carry different 
health risks, we separately analyzed correlations with IL-15 and 
NK cell activity. Our data, summarized graphically in Figure 7A, 
suggests that non-lymphoid tissues affect NK cells via multiple 
distinct interactions, but the strongest direct correlations were 
between IL-15 plasma levels and VAT, and an inverse correlation 
between NK function and muscle strength.
Our study appears to contrast with several studies of rodents 
and humans in which serum IL-15 level negatively associated 
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with VAT (32–37). As mentioned above, we found that plasma 
IL-15 positively associated with VAT. It is useful to consider 
that abdominal VAT may respond to IL-15 and that VAT itself 
produces IL-15 (27, 29). Most of the studies in rodents involved 
animals exposed to high nonphysiologic IL-15 levels via transgene 
expression or via injection; other studies utilized mice that were 
IL-15 knockouts. These extremes of IL-15 exposure might not 
be good models of the human condition. Prior human studies 
involved young adults and sometimes obese and lean groups dif-
fered significantly in age (33, 38). The contrasting outcomes in our 
study and past human studies may reflect age-related physiologi-
cal differences. One effect of IL-15 is to increase gene expression 
and metabolic activity in brown adipose tissue (39). Because the 
amount of brown adipose tissue usually declines with age (40), 
many elderly individuals might not respond to IL-15 by increas-
ing brown fat metabolic activity. Another possible explanation 
for this apparent contradiction is the amount of skeletal muscle 
mass in young and elderly adults and its correlation with adipose 
tissue mass. Obese young adults typically have more muscle mass 
than do lean young adults (41). Yet, fat mass is associated with a 
more rapid decline in muscle mass during aging (41). In addi-
tion, muscle strength declines rapidly in the elderly, much faster 
than loss of muscle mass, and may be a better measure of skeletal 
muscle health and function (42, 43).
Macrophages and DC functions decline with aging (13, 15, 44), 
making non-lymphoid sources of IL-15 relatively more impor-
tant. These factors are likely to influence IL-15-depedent NK cells 
and memory CD8 T  cells in the elderly. We propose that in 
elderly humans, VAT is a significant incremental source of IL-15 
(Figure 7B) and promotes NK cell homeostasis.
Growing evidence supports the hypothesis of a positive 
feedback loop between type 1 innate lymphoid cells (including 
NK  cells) and Mφ in people with a positive energy balance 
(30, 45–47). Adipocyte hypertrophy, fibrosis, hypoxia, and cell 
death cause release of inflammatory molecules, which stimulate 
adipose tissue Mφ (48). Stressed adipocytes express NKp46 
ligands that directly stimulate NK cells and probably other type 1 
innate lymphoid cells (47). In response to the inflammatory mol-
ecules, Mφ produce IL-12 and IL-15, which stimulate NK cells 
and other type 1innate lymphoid cells to produce IFN-γ, TNFα, 
and IL-6 (30, 45). These products, in turn, stimulate Mφ, setting 
up a positive feedback loop. Inflammatory cytokines, including 
IL-6 and TNFα, which affect skeletal muscle, the vasculature, 
and other tissues, cause pathologies associated with frailty and 
the metabolic syndrome (48, 49). Our data fit into this picture 
(Figure 7B). We found that IL-15 is elevated in relation to human 
VAT mass. Plasma C-reactive protein, a measure of inflamma-
tion, correlated strongly with plasma IL-15 (data not shown). We 
propose that IL-15 stimulates NK cells, both in a local paracrine 
fashion in VAT and in an endocrine fashion (Figure  7B). To 
explain the negative correlation between IL-15 and muscle 
strength, we propose that IL-15 itself and other inflammatory 
factors inhibit skeletal muscle (Figure 7B).
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